| scholarly article | Q13442814 |
| P2093 | author name string | K Sakai | |
| D J Volsky | |||
| X Y Ma | |||
| I Gordienko | |||
| P2860 | cites work | Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 |
| Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection | Q33575253 | ||
| Replication and pathogenesis of the AIDS virus. | Q34164817 | ||
| A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein | Q36682122 | ||
| Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation | Q36783052 | ||
| Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates | Q36811913 | ||
| Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis | Q36812230 | ||
| Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression | Q36830303 | ||
| Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual | Q36881607 | ||
| Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates | Q36882975 | ||
| Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes | Q37541575 | ||
| Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression | Q37678595 | ||
| The P30 movement protein of tobacco mosaic virus is a single-strand nucleic acid binding protein. | Q38341937 | ||
| Characteristics of HIV infection and pathogenesis | Q38764284 | ||
| Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes | Q39140204 | ||
| Retroviral etiology of the acquired immune deficiency syndrome (AIDS). | Q39461907 | ||
| Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex | Q40128160 | ||
| In vitro generation of an HTLV-III variant by neutralizing antibody | Q41345154 | ||
| pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane | Q41764642 | ||
| AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen | Q41830365 | ||
| Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity | Q43894349 | ||
| Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects | Q44982560 | ||
| Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome | Q45807119 | ||
| The sor gene of HIV-1 is required for efficient virus transmission in vitro | Q45831189 | ||
| Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus | Q45832058 | ||
| Differential ability of human immunodeficiency virus isolates to productively infect human cells | Q45833994 | ||
| Genomic diversity of human T-lymphotropic virus type III (HTLV-III). | Q45838359 | ||
| Low-cytopathic infectious clone of human immunodeficiency virus type I (HIV-I). | Q45847548 | ||
| The HIV 'A' (sor) gene product is essential for virus infectivity | Q45847960 | ||
| Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection | Q45848225 | ||
| Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells: efficient virus entry followed by delayed expression of its RNA and protein | Q45850368 | ||
| Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression | Q46323846 | ||
| West African HIV-2-related human retrovirus with attenuated cytopathicity | Q46870639 | ||
| Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions | Q48367096 | ||
| Assumptions of AIDS inquiry challenged | Q49075681 | ||
| CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. | Q52828546 | ||
| Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas | Q52831803 | ||
| Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. | Q55242378 | ||
| Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning. | Q55242825 | ||
| Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village. | Q55245570 | ||
| Biologically diverse molecular variants within a single HIV-1 isolate | Q57998184 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5765-5773 | |
| P577 | publication date | 1991-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity | |
| P478 | volume | 65 |
| Q35842465 | Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes |
| Q28482446 | Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7 |
| Q36650619 | Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages |
| Q39870640 | Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes |
| Q35838106 | Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo |
| Q40048199 | Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers. |
| Q36629686 | Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. |
| Q36654022 | Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1 |
| Q33784321 | Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. |
| Q39933471 | Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A. |
| Q39009412 | HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle |
| Q39880472 | Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro |
| Q41125504 | Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription |
| Q33785609 | Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells |
| Q36770468 | Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. |
| Q35860937 | Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles |
| Q35861652 | Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. |
| Q39872581 | Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells |
| Q40650704 | Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer. |
| Q24634681 | Pathogenesis of human immunodeficiency virus infection |
| Q36805150 | Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif. |
| Q36685112 | Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes |
| Q44966432 | Sequence analysis of HIV-1 vif gene in Spanish isolates. |
| Q36626506 | Subcellular localization of the Vif protein of human immunodeficiency virus type 1. |
| Q40467634 | The Human Immunodeficiency Virus Type 1 vif Gene: The Road from an Accessory to an Essential Role in Human Immunodeficiency Virus Type 1 Replication |
| Q36645938 | The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism |
| Q35851966 | The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. |
| Q37504507 | Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors |
| Q36651389 | Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells |
| Q33841920 | Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. |
| Q35866177 | vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. |
Search more.